How an endocrinologist actually decides In clinic, the decision between an oral GLP-1 pill and an injectable GLP-1 is built around the patient, not the medication
Boosting Growth Factors: BPC 157 may promote the production of growth factors, which are molecules that act as signals to cells, stimulating repair and renewal
,
Companies get around this by labeling it as a "research chemical not for human consumption." This means the product is completely unregulated, and you have no way of knowing if it's pure, sterile, or even contains the correct substance
Giorgino, Heterogeneity and similarities in GLP-1 receptor agonist cardiovascular outcomes trials
Victoza is a once-daily GLP-1 RA therapy for patients with type 2 diabetes Indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes and to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease
